Sean McNealy, the Co-Founder and President of Abacus Life, Inc. (NASDAQ:ABL), has sold 156,250 shares of the company's common stock. The transaction, conducted on November 21, 2024, was carried out at a price of $8 per share, amounting to a total sale value of $1.25 million. Following this transaction, McNealy holds 12,437,300 shares in the company. This move comes as part of McNealy's ongoing management and ownership activities within the firm.
In other recent news, Abacus Life Inc. has seen several updates. Following a successful $100 million common stock offering, B.Riley maintained its buy rating on the firm and raised the price target to $17.00. This decision was driven by increased earnings per share (EPS) estimates for the years 2024 to 2026, with the majority of the offering's proceeds expected to be used for policy purchases.
Piper Sandler also raised its price target for Abacus Life to $13.00, citing robust performance, revenue, and adjusted EBITDA that surpassed initial guidance. The firm also revised upward the adjusted EBITDA estimate for 2024 and core EPS estimates for 2024 to 2026.
In addition, Northland initiated coverage on Abacus Life shares with an Outperform rating and a price target of $13.50, indicating confidence in the company's future growth.
Abacus Life also reported strong financial results for the quarter ending June 30, 2024, with over $100 million in investments. The company expanded its assets under management through the strategic acquisitions of FCF Advisors and Carlisle Management Company SCA. Lastly, Abacus Life appointed Elena Plesco as its new Chief Capital Officer, signaling a focus on capital management strategies and global expansion efforts. These are recent developments for Abacus Life Inc.
InvestingPro Insights
As Sean McNealy's recent stock sale draws attention, it's worth examining Abacus Life's current financial position and market performance. According to InvestingPro data, Abacus Life has a market capitalization of $568.68 million, reflecting its position in the financial services sector. The company's revenue growth has been robust, with a 77.68% increase over the last twelve months as of Q3 2024, indicating strong business momentum.
However, investors should note that Abacus Life's stock has faced significant headwinds recently. InvestingPro Tips reveal that the stock has taken a big hit over the last week, with a 9.02% decline, and has fared poorly over the last month, dropping 15.06%. This short-term volatility may be a factor for investors to consider in light of McNealy's stock sale.
Despite these recent challenges, analysts remain optimistic about Abacus Life's prospects. An InvestingPro Tip suggests that net income is expected to grow this year, and analysts predict the company will be profitable this year. This positive outlook contrasts with the company's current unprofitable status over the last twelve months, hinting at a potential turnaround.
For those seeking a deeper understanding of Abacus Life's financial health and market position, InvestingPro offers 8 additional tips that could provide valuable insights for investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.